Electroacupuncture at ST36 acupoint regulates stem cells during experimental autoimmune encephalomyelitis

Area of Science:

• Neuroscience
• Immunology
• Regenerative Medicine

Background:

• Multiple Sclerosis (MS) is a debilitating neurological disease.
• Electroacupuncture (EA) is a recognized therapy for MS.
• The precise mechanism of EA involving stem cells in MS treatment remains unclear.

Purpose of the Study:

• To investigate the therapeutic effects of EA at the Zusanli (ST36) acupoint on experimental autoimmune encephalomyelitis (EAE), a model for MS.
• To elucidate the potential role of EA in modulating stem cell populations in vivo during EAE.

Main Methods:

• Establishment of EAE animal models.
• Administration of EA at the ST36 acupoint in EAE mice.
• Monitoring of clinical scores and body weight for 28 days.
• Assessment of central nervous system (CNS) demyelination, inflammatory cell infiltration, and stem cell markers (NSCs, HSCs, MSCs).

Main Results:

• EA treatment significantly suppressed demyelination and inflammatory cell infiltration in the EAE model.
• EA therapy led to decreased clinical scores and mitigated weight loss in EAE mice.
• The study observed increased proportions of neural stem cells (NSCs), hematopoietic stem cells (HSCs), and mesenchymal stem cells (MSCs) in EA-treated mice compared to controls.

Conclusions:

• EA at the ST36 acupoint represents an effective non-pharmacological treatment for EAE.
• EA reduces CNS inflammation and demyelination while promoting stem cell proliferation in EAE.
• Further research is warranted to fully understand the intricate mechanisms by which EA influences EAE progression.